



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Pharmaceutical Technology. 2. Final award ... Department of Pharmacy ... professional development in the pharmaceutical industry, or healthcare sector.
Typology: Study notes
1 / 7
This page cannot be seen from the preview
Don't miss anything!




**1. Programme title and designation Pharmaceutical Technology
Award Title Credit value
equivalent
Any special criteria
MSc Pharmaceutical Technology
3. Nested awards
Award Title Credit value
equivalent
Any special criteria
4. Exit awards
Award Title Credit value
equivalent
Any special criteria
PG Cert Biosciences 60 30 Modules - any combination to a minimum value of 60 credits
PG Dip Biosciences 120 90 Modules - any combination to a minimum value of 120 credits
5. Level in the qualifications framework M 6. Attendance
Full-time Part-time Distance learning Mode of attendance ^ ^ N/A
Minimum length of programme 12 months 24 months (^) N/A
Maximum length of programme 3 years 6 years N/A
7. Awarding institution/body King’s College London 8. Teaching institution King’s College London 9. Proposing department Department of Pharmacy 10. Programme organiser and contact details
Dr. M Thanou Department of Pharmacy Franklin-Wilkins Building Waterloo Campus Extension. 4807 [email protected]
11. UCAS code (if appropriate) NA 12. Relevant QAA subject benchmark/ professional and statutory body guidelines
There are no specific benchmark statements for this Masters programme. However, some relevant statements can be found in the QAA Subject Benchmark Statements for Pharmacy: http://www.qaa.ac.uk/crntwork/benchmark/phase2/pharm acy.htm
13. Date of production of specification 02 June 2005 (March 2007 Implementation CF)
PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22 nd^ September 2008 PAF Approved for 2009/10 by QA&AA: 3 rd^ September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2 nd^ March 2012
14. Date of programme review 2017/ 16. Educational aims of the programme - Provide an appropriate learning environment for a post-graduate programme that enables the delivery of high quality teaching and research methods - Provide an intellectual challenge to students at the postgraduate level - Encourage the student to be capable of working confidently and adopting a mature, professional and safe attitude to their work - Encourage the student to develop independent and self critical learning to maximise their own potential - Increase the depth of the student’s knowledge, technical and transferable skills in an integrated manner to enhance their current and future roles - Facilitate students to develop their transferable skills that include advanced study practices, precision and clarity in verbal and written communication, numeracy, team work and decision making - Enhance critical, analytical problem-solving skills, evidence-based decision making skills and the use of information technology - Establish a firm foundation for the pursuit of professional qualifications, and continuing professional development in the pharmaceutical industry, or healthcare sector - Enhance competence in numerical methods used in the pharmaceutical sciences - Provide an appreciation of the underlying science of biopharmaceutics and drug delivery - Provide an advanced understanding of drug absorption, distribution, metabolism, excretion and pharmacokinetics - Facilitate students to develop an advanced understanding of the principles of drug analysis by chromatographic and spectroscopic and other pharmacopoeial methods - Provide comprehensive understanding of the drug development process and the role of regulatory agencies - Facilitate students to develop the ability to critically review the scientific literature, critically analyse information, synthesise and summarise conclusions - Provide a comprehensive understanding of formulation and production of medicines, including the assessment and control of quality of manufactured products 17. Educational objectives of the programme/programme outcomes
The programme provides opportunities for students to develop and demonstrate knowledge and understanding and skills in the following areas:
All areas are defined in detail below
Knowledge and understanding The programme provides a knowledge and understanding of the following:
Subject Knowledge
These are achieved through the following teaching/learning methods and strategies :
The modules are taught by subject specialists, including visiting professionals.
PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22 nd^ September 2008 PAF Approved for 2009/10 by QA&AA: 3 rd^ September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2 nd^ March 2012
Student centred learning, involving library- based research, information and data retrieval and presentations will be encouraged to reinforce and enhance these skills.
Practical skills :
These are achieved through the following teaching/learning methods and strategies : Subject practical skills 14 – 27 are developed in a coordinated and progressive manner throughout the programme; in the laboratory classes, workshop tutorials, computer-based sessions and during the research project. Practicals associated with The Principles of Analytical Techniques module will train student in GLP criteria, essential for employment in industry. Critical analysis skills are developed throughout the programme in both laboratory-based and class-based scenarios in preparation for the critical evaluation of the literature and generated data within the written research thesis/dissertation.
Assessment : A variety of assessment methods are used to assess subject practical skills.
Skills 14 and 15 are assessed during the project and via the various practical sessions within the different modules. These include the requirement to produce written laboratory reports, critically evaluate data generated by applying appropriate statistical methods to evaluate the pharmaceutical data.
Skills 16 – 19 and 22 - 24 are assessed during the practical workshops, written laboratory reports, coursework essays and individual coursework assignments.
Skills 20 and 21 are assessed during workshops and associated coursework assignments
Skills 25 - 27 are assessed during the project practical, presentation and final written dissertation.
PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22 nd^ September 2008 PAF Approved for 2009/10 by QA&AA: 3 rd^ September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2 nd^ March 2012
Generic/transferable skills :
These are achieved through the following teaching/learning methods and strategies :
Generic/transferable skills detailed in points 28 – 35 are developed in a contextualised manner throughout the programme. These skills are highlighted using problem solving, practical laboratory sessions, IT, information retrieval, CAL, poster and presentation skills. These skills are enhanced during tutorials, seminars, laboratory classes, workshop tutorials and coursework assignments.
Assessment : All generic/transferable skills are assessed through the various assessment strategies adopted throughout the programme. A variety of assessment methods are used to assess transferable key skills.
Skill 28 is assessed via oral presentations and workshop seminars.
Skills 29 – 32 are assessed via various coursework assignments within the different modules, the research project and workshop seminars; including CAL.
Skills 32 - 34 are assessed during the project, problem-solving assignments, practical reports and the final written dissertation.
Skill 35 is developed throughout the programme by adhering to deadlines and completing the written dissertation.
18. Statement of how the programme has been informed by the relevant subject benchmark statement(s)/professional, regulatory and statutory body guidelines
There are no specific benchmark statements for this programme; however, attention has been placed upon the QAA benchmarking statements for pharmacy so that the programme and curriculum are informed by the specific subject knowledge, abilities and skills outlined in these statements
19. Programme structure and award requirements
(a) numbers of introductory, core, compulsory and optional modules to be taken in each year of the programme with related credit values MSc 5 core modules (180 Credits in total).* see below
PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22 nd^ September 2008 PAF Approved for 2009/10 by QA&AA: 3 rd^ September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2 nd^ March 2012
Programme Structure
Title Credit level
Credit value
Status (I, Cr, Cp, O) for each type of programme Progression
Assessment
Single Joint
Major/ minor Single Joint
Major/ minor
7BBPM010 Principles of Drug Delivery and Disposition 7 30 Cr Yes
Examination, Coursework 7BBPM011 Principles of Analytical Techniques, Numerical Methods and Regulatory Affairs 7 30 Cr Yes
Examination, Coursework
7BBPM017 Drug Delivery: Solid Dosage Forms 7 30 Cr Yes
Examination, Coursework 7BBPM018 Drug Delivery: Liquid Dosage Forms and Microbiology 7 30 Cr Yes
Examination, Coursework
7BBPM014 Research Project 7 60 CrCp* Yes
Written Thesis, Oral Presentation 7BBPM019 Literature Review Project 7 60 CrCp* No Research Review Paper Poster presentation, research records, student performance
20. Marking criteria
All modules will be marked in accordance with the Schools marking criteria where such exist or else in accordance with the Colleges general marking criteria.
PAF originally approved by QA&AA: 31 May 2007 PAF approved for 2008/9 by QA&AA: 22 nd^ September 2008 PAF Approved for 2009/10 by QA&AA: 3 rd^ September 2009 PAF modified by ASQ re: exit awards: 8 April 2010 PAF finalised for 2011/12: 23 August 2011 PAF modified by QAS for 2012/13: 2 nd^ March 2012